These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11768158)

  • 1. Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.
    Gilat T; Leikin-Frenkel A; Goldiner L; Laufer H; Halpern Z; Konikoff FM
    Lipids; 2001 Oct; 36(10):1135-40. PubMed ID: 11768158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.
    Gilat T; Leikin-Frenkel A; Goldiner I; Halpern Z; Konikoff FM
    Hepatology; 2002 Mar; 35(3):597-600. PubMed ID: 11870372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty acid bile acid conjugates (FABACs) on biliary lithogenesis: potential consequences for non-surgical treatment of gallstones.
    Konikoff FM; Gilat T
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):171-5. PubMed ID: 16089349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC).
    Gilat T; Leikin-Frenkel A; Goldiner I; Juhel C; Lafont H; Gobbi D; Konikoff FM
    Hepatology; 2003 Aug; 38(2):436-42. PubMed ID: 12883488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile.
    Wang DQ; Paigen B; Carey MC
    J Lipid Res; 1997 Jul; 38(7):1395-411. PubMed ID: 9254065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Innovations in the medical treatment of gallstones and fatty liver: FABACs (Fatty Acid Bile Acid Conjugates)].
    Keizman D; Goldiner I; Leikin-Frenkel A; Konikoff FM
    Harefuah; 2008 Apr; 147(4):344-9, 373, 372. PubMed ID: 18686819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal sterol output is increased by arachidyl amido cholanoic acid (Aramchol) in rats.
    Leikin-Frenkel A; Weinbroum AA; Leikin-Gobbi D; Krupitzky L; Goldiner I; Shafat L; Gilat T; Konikoff FM
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):131-3. PubMed ID: 14748731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in mice.
    Leikin-Frenkel A; Parini P; Konikoff FM; Benthin L; Leikin-Gobbi D; Goldiner I; Einarsson C; Gilat T
    Arch Biochem Biophys; 2008 Mar; 471(1):63-71. PubMed ID: 18167305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution of cholesterol gallstones by bile acids in hamsters.
    Sue SO; Bonorris GG; Marks JW; Vimadalal S; Schoenfield LJ
    Am J Med Sci; 1982; 284(1):18-23. PubMed ID: 7091181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid bile acid conjugates (FABACs)--new molecules for the prevention of cholesterol crystallisation in bile.
    Gilat T; Somjen GJ; Mazur Y; Leikin-Frenkel A; Rosenberg R; Halpern Z; Konikoff F
    Gut; 2001 Jan; 48(1):75-9. PubMed ID: 11115826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
    Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
    Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of various cholesterol crystals in bile from patients with gallstones.
    Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
    Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile.
    Fischer S; Dolu MH; Zündt B; Meyer G; Geisler S; Jüngst D
    Eur J Clin Invest; 2001 Sep; 31(9):789-95. PubMed ID: 11589721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and a thickened mucus layer in mice with cholesterol gallstones.
    Rege RV; Prystowsky JB
    J Surg Res; 1998 Jan; 74(1):81-5. PubMed ID: 9536979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophilic bile acids: prevention and dissolution experiments in two animal models of cholesterol cholelithiasis.
    Cohen BI; Mikami T; Ayyad N; Ohshima A; Infante R; Mosbach EH
    Lipids; 1995 Sep; 30(9):855-61. PubMed ID: 8577230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of ursodeoxycholic acid and ursocholic acid on the formation of biliary cholesterol crystals in mice.
    Uchida K; Akiyoshi T; Igimi H; Takase H; Nomura Y; Ishihara S
    Lipids; 1991 Jul; 26(7):526-30. PubMed ID: 1943496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hyocholic acid on the prevention and dissolution of biliary cholesterol crystals in mice.
    Dusserre JP; Montet AM; Montet JC
    Can J Physiol Pharmacol; 1988 Aug; 66(8):1028-34. PubMed ID: 3179836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems.
    Wang DQ; Carey MC
    J Lipid Res; 1996 Mar; 37(3):606-30. PubMed ID: 8728323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice.
    Wang DQ; Tazuma S
    J Lipid Res; 2002 Nov; 43(11):1960-8. PubMed ID: 12401895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary and systemic effects of fatty acid bile acid conjugates.
    Konikoff FM; Leikin-Frenkel A; Goldiner I; Michowitz M; Brezowski E; Harats D; Gilat T
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):649-55. PubMed ID: 12840677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.